Emulsification of liposomes with incomplete Freund's adjuvant: Stability of the liposomes and the emulsion

Journal of Liposome Research

Volumn 8, Issue 2, 1998, Pages 183-194

  Muderhwa, Jean M ^a,b   Rothwell, Stephen W ^a   Alving, Cari R ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b Jenner Biotherapies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT; LIPOSOME;

ANIMAL CELL; ARTICLE; CELL MEMBRANE PERMEABILITY; DRUG FORMULATION; EMULSION; IMMUNIZATION; LIPID BILAYER; LIPID COMPOSITION; LIPID METABOLISM; MEMBRANE STABILIZATION; NONHUMAN; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL; PROTEIN STABILITY;

EID: 0031834957     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.3109/08982109809035525     Document Type: Article

References (22)

1. Freund, J. 1956. The mode of action of immunologic adjuvants. Adv. Tuberc. Res. 1:130-148.
2. Hilleman M.R. 1966. Critical appraisal of emulsified oil adjuvants applied to viral vaccines. Progr. Med. Viral. 8:131-182.
3. Alving, C.R., Wassef, N.M., and Richards, R.L. 1996 Use of adjuvants for enhancement of antibody responses. In "Weir's Handbook of Experimental Immunology" 5th Edition, L.A. Herzenberg, D. M. Weir, C. Blackwell, and L. A. Herzenberg (Eds.). Blackwell Science, Cambridge, MA, p. 87.1-87.10
4. Salk J.E., Contakos M., Laurent A.M., Sorensen M., Rapalski A.J., Simmons I.H. & Sandberg H. 1953 Use of adjuvants in studies on influenza immunization. 3. Degree of persistence of antibody in human subjects two years after vaccination. J. Am. Med. Assn. 151:1169-1175.
5. Cutler J.C., Lesesne L., & Vaughn I. 1962 Use of poliomyelitis virus vaccine in light mineral oil adjuvant in a community immunization program and report of reactions encountered. J. Allerg. 33:193-209.
6. Edelman R. 1980. Vaccine adjuvants. Rev. Infect. Dis. 2:370-382.
7. rd edition." D.M. Weir (Ed.). Blackwell Scientific Publications, Oxford, p. A3.1-A3.15.
8. Uemura, K., Nicolotti, R.A., Six, H.R., and Kinsky, S.C. 1974. Antibody formation in response to liposomal model membranes sensitized with N-substituted phosphatidylethanolamine derivatives. Biochemistry 13:1572-1578.
9. Kochibe, N., Nicolotti, R.A., Davie, J.M., and Kinsky, S.C. 1975. Stimulation and inhibition of anti-hapten responses in guinea pigs immunized with hybrid liposomes. Proc. Natl. Acad. Sci. U.S.A. 72:4582-4586.
10. Nicolotti, R.A., Kochibe, N., and Kinsky, S.C. 1976. Comparative immunogenic properties of N-substituted phosphatidylethanolamine derivatives and liposomal model membranes. J. Immunol. 117:1898-1902.
11. Kinsky, S.C., and Nicolotti, R.A. 1977. Immunological properties of model membranes. Ann. Rev. Biochem. 46:49-67.
12. Becher, P. 1965. Emulsions: Theory and Practice, American Chemical Society Monograph Series, Reinhold Publishing Co., New York.
13. Albert, E.C., Wallach, D.F.H., and Mathur, R. Lipid vesicle containing water-in-oil emulsions. U.S. Patent No. 5,256,422, issued Oct. 26, 1993.
14. Yoshioka, T., Skalko, N., Gursel, M., Gregoriadis, G., and Florence, A.T. 1995. A non-ionic surfactant vesicle-in-water-in-oil (v/w/o) system: Potential uses in drug and vaccine delivery. J. Drug Targ. 2:533-539.
15. nd ed., Vol. III, G. Gregoriadis (Ed.). CRC Press, Boca Raton, FL, p. 317-343.
16. Moncada, C., Torres, V., Israel, Y. 1993. Simple method for the preparation of antigen emulsions for immunization. J. Immunol. Meth. 162:133-140.
17. Verma, J.N., Wassef, N.M., Wirtz, R.A., Atkinson, C.T., Aikawa, M., Loomis, L.D. and Alving, C.R. Phagocytosis of liposomes by macrophages: intracellular fate of liposomal malaria antigen. 1991. Biochim. Biophys. Acta, 1066:229-308.
18. Zhou, R., Watkins, S.C., and Huang, L. (1994). Characterization and kinetics of MHC class I-restricted presentation of a soluble antigen delivered byliposomes. Immunobiol. 190:35-52.
19. Rao, M., Rothwell, S.W., Wassef, N.M., Pagano, R.E. and Alving, C.R. 1997. Visualization of peptides derived from liposome-encapsulated proteins in the trans-Golgi area of macrophages. Immunol. Lett. 59:99-105.
20. Alving, C.R. and Wassef, N.M. Cytotoxic T lymphocytes induced by liposomal antigens: Mechanisms of immunologic presentation. 1994. AIDS Res. Human Retrovir. 10(Suppl. 1):S91-S94.
21. Muderhwa, J.M., Wassef, N.M., Spitler, L.E., and Alving, C.R. 1996. Effects of aluminum adjuvant compounds, Tweens and Spans on the stability of liposome permeability. Vaccine Res. 5(1):1-13.
22. Goldenthal, K.L., Cavagnaro, J.A., Alving, C.R. and Vogel, F.R. Safety evaluation of vaccine adjuvants. 1993. AIDS Res. Hum. Retrovir. 9(Suppl. 1):S47-S51.